Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 20 grams of protein | Experimental | Participants will be randomized (like flipping a coin) to a post-workout protein consisting of 20 grams of whey protein. The protein will be 100% cold processed and micro-filtered, non-GMO grass-fed whey protein isolate, soy and gluten free, unflavored, and unsweetened. This will include Irish Dairy, which is whey protein isolate and soy lecithin, and Raw GrassFed Whey, which is whey protein concentrate. Participants will not know which amount of protein they receive. |
|
| 60 grams of protein | Experimental | Participants will be randomized (like flipping a coin) to a post-workout protein consisting of 60 grams of whey protein. The protein will be 100% cold processed and micro-filtered, non-GMO grass-fed whey protein isolate, soy and gluten free, unflavored, and unsweetened. This will include Irish Dairy, which is whey protein isolate and soy lecithin, and Raw GrassFed Whey, which is whey protein concentrate. Participants will not know which amount of protein they receive. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Whey protein (20 grams) | Dietary Supplement | 20 grams of whey protein |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in muscle mass and fat mass (pounds) at completion of chemotherapy | Baseline and at program completion (within 4 weeks of exercise completion). |
| Measure | Description | Time Frame |
|---|---|---|
| Response to Chemotherapy Assed Via the Guidelines or the Response evaluation criteria in solid tumors (RECIST) | Response to chemotherapy will be assessed via the guidelines or the Response evaluation criteria in solid tumors (RECIST) criteria version 1.1 before and after chemotherapy with radiographic interpretation on either MRI of the breast or, if unable to get an MRI, PET/CT scan. | Chemotherapy response assessment is at program completion (within 4 weeks of exercise completion) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Clinical Trials Contact | Contact | 412-330-6151 | ctgov@ahn.org |
| Name | Affiliation | Role |
|---|---|---|
| Colin Champ, MD | AHN Radiation Oncology | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Allegheny General Hospital | Recruiting | Pittsburgh | Pennsylvania | 15212 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
| Whey protein (60 grams) |
| Dietary Supplement |
60 grams of whey protein. |
|
| Changes in EuroQol-5 Dimensions (EQ-5D) at completion of chemotherapy assessment | EuroQol-5 Dimensions-5 Levels total score for the 5 questions ranges from 5 (no problems on any dimension) to 25 (extreme problems on all dimensions). This is calculated by assigning scores of 1 (minimum), 2, 3, 4, and 5 (maximum), to the response categories of "no problems", "slight problems", "moderate problems", "severe problems", and "extreme problems"/"unable to", respectively. Higher scores mean worse outcomes. | Baseline assessment (prior to program) and at exercise program completion (at 24 weeks). |
| Changes in Patient Health Questionnaire-9 (PHQ9) depression score at completion of chemotherapy assessment | Patient Health Questionnaire-9 total score for the 9 questions ranges from 0 (no depression) to 27 (highest level of depression). This is calculated by assigning scores of 0 (minimum), 1, 2, and 3 (maximum), to the response categories of "not at all", "several days", "more than half the days", and "nearly every day", respectively. Higher scores mean a worse outcome. | Baseline assessment (prior to program) and at exercise program completion (at 24 weeks). |
| Changes in General Anxiety Disorder-7 (GAD7) anxiety score at completion of chemotherapy assessment | General Anxiety Disorder-7 total score for the seven questions ranges from 0 (no anxiety) to 21 (highest level of anxiety). This is calculated by assigning scores of 0 (minimum), 1, 2, and 3 (maximum), to the response categories of "not at all", "several days", "more than half the days", and "nearly every day", respectively. Higher scores mean a worse outcome. | Baseline assessment (prior to program) and at exercise program completion (at 24 weeks). |
| Changes in activity levels via Godin Leisure-Time Exercise Questionnaire | Godin Leisure-Time Exercise Questionnaire is used to measure a person's frequency and intensity of exercise during a typical week. A Godin Scale Score of 24 units or more is interpreted as Active, 14 - 23 units is Moderately Active, and less than 14 units is Insufficiently Active/Sedentary. | Baseline assessment (prior to program) and at exercise program completion (at 24 weeks). |
| Changes in resting metabolic rate at completion of chemotherapy | Baseline and at program completion (within 4 weeks of exercise completion). |
| Changes in body composition at completion of chemotherapy, including fat-free mass in pounds. | Baseline and at program completion (within 4 weeks of exercise completion). |
| Changes in Y-Balance Test Scores at baseline and at completion of chemotherapy | Reach distances in three directions (anterior, posteromedial, and posterolateral) measured in centimeters. | Baseline and at program completion (within 4 weeks of exercise completion). |
| Changes in Functional Mobility Score at baseline and at completion of chemotherapy | During the test, 7 movement patterns are assessed and each one is rated between 0 and 3 by an examiner. These movements include the deep squat, hurdle step, inline lunge, shoulder mobility test, active straight leg raise, trunk stability push up, and rotary stability test. A score of zero is given if any pain is felt during the movement, 1 if the subject is unable to perform the movement, 2 if the subject performs the movement through compensatory movements, and 3 if the movement is performed correctly. Each movement score is summed and a final score out of 21 is calculated. A score below 14 is felt to identify individuals at risk of injury. | Baseline and at program completion (within 4 weeks of exercise completion). |
| Changes in phase angle at completion of chemotherapy | Phase angle is calculated via bioimpedance analysis and is measured in degrees. | At program completion (at 24 weeks) |
| ID | Term |
|---|---|
| D009369 | Neoplasms |
| D001943 | Breast Neoplasms |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D000067816 | Whey Proteins |
| ID | Term |
|---|---|
| D008894 | Milk Proteins |
| D000080224 | Animal Proteins, Dietary |
| D004044 | Dietary Proteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D000067796 | Whey |
| D008892 | Milk |
| D003611 | Dairy Products |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
| D019602 | Food and Beverages |
Not provided
Not provided